Efficacy of Serratus Anterior Plane Block Mastectomy
Ključne riječi
Sažetak
Opis
The aim of this study is to compare the efficacy of ultrasound-guided serratus anterior plane block with bupivacaine/ magnesium versus bupivacaine/ nalbuphine in breast cancer surgery.
Patients and methods nclusion criteria:
-ASA I and II female patients, age 25-60 undergoing breast cancer surgery
Exclusion criteria:
- Patient refusal
- Contraindications for regional blocks (eg. Infection at the injection site, coagulopathy)
- Allergy to the drugs used in the study
- Chronic pain therapy,
- BMI more than 30 kg/m2
Datumi
| Posljednja provjera: | 01/31/2020 |
| Prvo podneseno: | 05/05/2019 |
| Predviđena prijava poslana: | 05/07/2019 |
| Prvo objavljeno: | 05/09/2019 |
| Posljednje ažuriranje poslano: | 02/10/2020 |
| Posljednje ažuriranje objavljeno: | 02/11/2020 |
| Stvarni datum početka studija: | 05/06/2019 |
| Procijenjeni datum primarnog završetka: | 11/30/2019 |
| Procijenjeni datum završetka studije: | 11/30/2019 |
Stanje ili bolest
Intervencija / liječenje
Procedure: serratus anterior plan block
Faza
Grupe ruku
| Ruka | Intervencija / liječenje |
|---|---|
| Active Comparator: GBM:( bupivacaine/magnesium sulphate) serratus plane block will performed in the supine position under strict aseptic conditions before induction of anesthesia.
GBM:( bupivacaine/magnesium sulphate): will receive bupivacaine 30 ml 0.25 and 500 mg magnesium sulphate | |
| Active Comparator: GBN: ( bupivacaine/nalpuphin) serratus plane block will performed in the supine position under strict aseptic conditions before induction of anesthesia.. ( bupivacaine/nalpuphin):received bupivacaine 30 ml 0.25 % and nalpuphine 0.2mg/kg. |
Kriterij prihvatljivosti
| Dobni uvjeti za studiranje | 25 Years Do 25 Years |
| Spolovi koji ispunjavaju uvjete za studij | Female |
| Prihvaća zdrave volontere | Da |
| Kriteriji | Inclusion Criteria: - ASA I and II female patients, age 25-60 undergoing breast cancer surgery Exclusion Criteria: - -Patient refusal - Contraindications for regional blocks (eg. Infection at the injection site, coagulopathy) - Allergy to the drugs used in the study - Chronic pain therapy, - BMI more than 30 kg/m2 |
Ishod
Primarne mjere ishoda
1. time to first analgesic requirements in minutes [change from base line for 24 hours]
